LCE2D: A Small Proline-Rich-Like Epidermal Differentiation Complex Protein 1A as A Drug Target Or Biomarker

Target Name: LCE2D

NCBI ID: G353141

LCE2D

LCE2D: A Small Proline-Rich-Like Epidermal Differentiation Complex Protein 1A as A Drug Target Or Biomarker

Unlocking the Potential of LCE2D: A Small Proline-Rich-Like Epidermal Differentiation Complex Protein 1A as a Drug Target or Biomarker

Abstract:

The rapid development of drug-resistant skin diseases has led to an increased interest in the search for new therapeutic targets. One promising candidate for drug discovery is the small proline-rich-like epidermal differentiation complex protein 1A (LCE2D), which has been identified as a potential drug target or biomarker. In this article, we will explore the biology of LCE2D, its potential drug-targeting properties, and its potential as a biomarker for the diagnosis and treatment of skin diseases.

Introduction:

Skin diseases are a common and often painful condition that affect millions of people worldwide. The treatments available for these diseases are often limited in their effectiveness and can have potential side effects. As such, there is a growing need for new therapeutic targets that can provide effective and safe treatments for skin diseases. One promising candidate for drug discovery is LCE2D, a small proline-rich-like epidermal differentiation complex protein 1A (ECP) that has been identified as a potential drug target or biomarker.

Biological background:

Skin diseases are common and painful conditions that affect millions of people worldwide. Treatment options for these conditions are often limited and may have potential side effects. Therefore, there is an increasing need for new therapeutic targets. One promising candidate therapeutic target is LCE2D, a small proline-rich-like epidermal differentiation complex 1A (ECP) that has been identified as a potential drug target or biomarker. In this article, we explore the biology of LCE2D, its properties as potential drug targets or biomarkers, and its possible implications for the diagnosis and treatment of skin diseases.

Properties of LCE2D:

LCE2D is a ~200 amino acid peptide composed of multiple proteins, including keratin proteases, keratinocytes, keratin cross-linking proteins, N-acetylmuramin, lamellar keratin, etc. LCE2D is expressed in skin tissue, especially epidermis and hair follicle tissue. Under in vitro culture conditions, LCE2D can promote the growth of keratinocytes.

Protein Name: Late Cornified Envelope 2D

Functions: Precursors of the cornified envelope of the stratum corneum

The "LCE2D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LCE2D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets